LONDON (Reuters) – Artificial intelligence company Babylon Health said it would invest $100 million to double its team of engineers and scientists in London and expand its capabilities to manage chronic diseases such as diabetes and depression.Babylon has developed an AI-powered platform that it says can assess symptoms and diagnose illness to the same capability as a family physician a claim it supported by setting the technology the same exam questions that doctors are required to take.SPONSOREDFounder and chief executive Ali Parsa said the next step was using the technology to assist with the management of chronic diseases, benefiting patients and doctors alike.The more difficult part is what we have already done, which is to turn the machine into a generalist, he said in an interview on Thursday. Management of each of these diseases now is easier because you have so many apps, but the problem is they do not connect.Babylon was building technology able to assess and monitor a chronic disease in the context of a patients overall health, including the presence of other chronic conditions, he added.

Source: Click here

Facebook Comments